The following guideline can be ordered through the address listed in the "Source/Publisher"-category. In cases in which you can order through the Internet we have established a hyperlink.

2004/C 24/06 Note for guidance on minimising the risk of transmitting animal spongiform encephalopathyagents via human and veterinary medicinal products (EMEA/410/01 Rev. 2 - October 2003) adopted by the Committee for Proprietary Medicinal Products (CPMP)

Short Title:
2004/C 24/06

European Commission

Document Type:
Note for guidance
This revision of the TSE (Transmissible Spongiform Encephalopathy) note for guidance has been undertaken to introduce, inter alia, risk assessment into the regulatory compliance process, to provide clarification on a variety of terms and classifications, and to take into account advances in scientific knowledge, Community legislation and rules affecting the authorisation of medicinal products for human or veterinary use.

Go back

GMP Conferences by Topics